MyLeukemiaTeam

While the search results don't directly address experiences of patients who received clinical trials after failed CAR-T therapy, they do indicate that scientists are actively working on improving CAR-T cell therapy treatments. Research is ongoing to develop modified versions that might be more effective and have fewer side Show Full Answer

While the search results don't directly address experiences of patients who received clinical trials after failed CAR-T therapy, they do indicate that scientists are actively working on improving CAR-T cell therapy treatments. Research is ongoing to develop modified versions that might be more effective and have fewer side effects.

Current CAR-T therapy shows impressive remission rates of up to 94% for B-cell leukemias, but researchers acknowledge that side effects like CRS and neurotoxicity remain challenging obstacles to overcome. Scientists are specifically working on developing an "off-the-shelf" version of CAR-T therapy that would be cheaper, quicker, and more easily available. This could potentially provide additional treatment options for patients who didn't succeed with traditional CAR-T therapy.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

BiTE vs. CAR-T Cell Therapy: A Leukemia Treatment Comparison

Understanding Immunotherapy for ALL